The Globe and Mail reports in its Friday edition that Acumen Capital analyst Jim Byrne has reaffirmed his "buy" recommendation for Sangoma Technologies. The Globe's David Leeder writes in the Eye On Equities column that Mr. Byrne chipped his share target back by $2 to $8. Analysts on average target the shares at $11.52. Mr. Byrne is of a mind that Sangoma Technologies' near-term outlook is "a little less clear" as its new leadership group delineates its strategy. Mr. Byrne says in a note: "We believe the long-term story for Sangoma is stronger now with the new senior leadership team in place. They are an experienced team with the opportunity to take the company to the next phase of its development. The focus on assembling the right services mix, the proper bundling of those services, and targeting the best markets for Sangoma should happen over the next few quarters. ... Sangoma shares trade at a significant discount to the peer group and we believe the shares are quite attractive at these levels. Like Sangoma, peers such as 8x8 and Ring have been under pressure with significant margin compression in the past two years." The Globe reported on Feb. 14 that Canaccord rated Sangoma "buy" when it was worth $4.60.